ADVISORY, March 5, 2015 (GLOBE NEWSWIRE) -- What: Summit Therapeutics PLC (Nasdaq:SMMT), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C ...

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the ...

In recent trading, shares of Summit Therapeutics Inc (Symbol: SMMT) have crossed above the average analyst 12-month target price of $35.57, changing hands for $36.70/share. When a stock reaches ...

Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning. Summit has been a tremendous winner over the past ...

Deep-pocketed investors have adopted a bullish approach towards Summit Therapeutics (NASDAQ:SMMT), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Summit Therapeutics PLC (SMMT) closed the last trading session at $25.85, gaining 10.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Below is Validea's guru fundamental report for SUMMIT THERAPEUTICS INC (SMMT). Of the 22 guru strategies we follow, SMMT rates highest using our Quantitative Momentum Investor model based on the ...

To say this has been a big year for Summit Therapeutics (NASDAQ: SMMT) would be a huge understatement. The stock has risen over 600% since the end of 2023, thanks to surprisingly positive trial ...

Average portfolio weight of all funds dedicated to SMMT is 0.04%, an increase of 639.83%. Total shares owned by institutions increased in the last three months by 299,914.92% to 34,451K shares.

Summit Therapeutics SMMT is a clinical-stage biopharmaceutical company focused on the development and marketing of medicinal therapies to treat oncology indications with serious unmet needs ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Summit Therapeutics (SMMT) one of those stocks right now?